Hamzei Analytics Financial Network

Our mission is to provide valuable trading insights to advanced traders for analysis of mass behavior in the equity, bond, commodity and currency markets.

Monday, October 22, 2007

HOTS Weekly Options Commentary

›
Peter Stolcers With the exception of financial stocks, most sectors have been beating expectations. Financials are not some small little par...
Friday, October 19, 2007

Market Timing

›
Fari Hamzei I wrote a piece for FOX biz channel around 830 am PDT this morning, about my reasons why DOW should close about -350 to -500 to...
Saturday, October 13, 2007

HOTS Weekly Options Commentary

›
Peter Stolcers Last week a stable Employment Report was released and the market surged higher. Despite mixed earnings announcements and soft...
Friday, October 12, 2007

Equity Index Update (Special Edition)

›
Brad Sullivan The index markets suffered through a sharp decline in the afternoon trade after a JP Morgan analyst cut revenue estimates for ...

Random Comments

›
Fil Zucchi I will refrain from too many comments on the nasty reversal we saw yesterday, since there are far smarter technical eyes in this ...
Friday, October 5, 2007

Bull Run in the Silver and Gold Index (XAU)

›
Tim Ord The $XAU chart above dates back to 1985. At the bottom of the chart is the Price Relative to gold Ratio (PRTG). PRTG ratio measure...
Sunday, September 30, 2007

HOTS Weekly Options Commentary

›
Peter Stolcers This week the market fell into a very tight 30 point trading range on the S&P 500. In the absence of news, light directi...
Friday, September 21, 2007

HOTS Weekly Options Commentary

›
Peter Stolcers Last week, the Fed pulled a surprise move when it lowered interest rates and the discount window rate by .5%. The S&P 500...
Thursday, September 20, 2007

Home Builders, CDs and Corp. Paper

›
Fil Zucchi The following piece was written on August 27: “We all know the treatment housing stocks have received and at this point few seem...
Wednesday, September 19, 2007

Pink slips at the FDA will equate to red ink for biotech investors

›
David Miller Andy von Eschenbach, FDA Commissioner, says he’ll have to issue 2,000 60-day pink slips at the FDA if Congress and the Presiden...
‹
›
Home
View web version
Powered by Blogger.